Treatment of arterial thrombosis in children: Methods and mechanisms.

Mattia Rizzi, Manuela Albisetti
Author Information
  1. Mattia Rizzi: Hematology/Oncology Unit, Division of Pediatrics, University Hospital CHUV, Lausanne, Switzerland.
  2. Manuela Albisetti: Division of Hematology, University Children's Hospital, Switzerland; Children's Research Center, University Children's Hospital, Switzerland. Electronic address: manuela.albisetti@kispi.uzh.ch.

Abstract

Arterial thrombosis is increasingly recognized in children and is mostly related to the presence of an arterial catheter or an ischemic stroke. Treatment of children with arterial thrombosis varies widely and consists on the administration of the common available anticoagulant und antiplatelet drugs. No evidence-based guidelines are available so far to prefer one treatment approach to another. Data in adults indicate that understanding the pathomechanism and composition of arterial thrombosis is crucial for choosing the most efficient and safe antithrombotic drug. This review will briefly summarize new insights on the pathomechanism and composition of arterial thrombosis in adults and describe available antithrombotic treatment modalities currently used n children.

Keywords

MeSH Term

Adult
Antithrombins
Child
Fibrinolytic Agents
Heparin
Humans
Platelet Aggregation Inhibitors
Thrombectomy
Thrombosis
Vitamin K

Chemicals

Antithrombins
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Vitamin K
Heparin

Word Cloud

Created with Highcharts 10.0.0thrombosisarterialchildrenTreatmentavailableArterialtreatmentadultspathomechanismcompositionantithromboticMethodsincreasinglyrecognizedmostlyrelatedpresencecatheterischemicstrokevarieswidelyconsistsadministrationcommonanticoagulantundantiplateletdrugsevidence-basedguidelinesfarpreferoneapproachanotherDataindicateunderstandingcrucialchoosingefficientsafedrugreviewwillbrieflysummarizenewinsightsdescribemodalitiescurrentlyusednchildren:mechanismsChildren

Similar Articles

Cited By